All articles tagged: Respiratory syncytial virus pneumonia (J12.1)


HealthDay 10 July at 10.23 PM Nirsevimab Effective Against RSV-Linked Bronchiolitis Hospitalization Nirsevimab therapy is effective for reducing the risk for hospitalization for respiratory syncytial virus (RSV)-associated bronchiolitis among infants, according to a study published in the July 11 issue of the New England Journal of Medicine.Zein Assad, M.D., from the Robert Debré University Hospital in Paris, and colleagues conduct # Pediatrics # Pharmacy # Infectious Disease # Pulmonology 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
HealthDay 27 June at 11.32 AM CDC Strengthens RSV Vaccine Advice for Those Over 75 In new vaccination guidance issued Wednesday, U.S. health officials now recommend that all Americans aged 75 and older get an RSV vaccine before fall arrives.However, those a bit younger -- ages 60 to 74 -- should only seek the shot if they are vulnerable to severe RSV because of chronic medical conditions such as lung or heart disease, or if # Internal Medicine # Pharmacy # Infectious Disease # Geriatrics 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
HealthDay 16 January at 11.49 PM CDC: Although Season Not Over, Flu Activity Is Slowing Down For the first time in months, there has been "a single-week decrease" in flu activity, according to data released by the U.S. Centers for Disease Control and Prevention.But health officials warn that the flu season is far from over, with a surge expected shortly. "Folks try not to seek care # Nursing # Internal Medicine # Emergency Medicine # Pharmacy 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
HealthDay 28 December at 11.36 PM Nearly Half of U.S. COVID-19 Cases Now Caused by JN.1 Variant The JN.1 variant, a descendant of the variant BA.2.86, now accounts for 44 percent of COVID-19 cases, up from roughly 7 percent in late November, the latest data from the U.S. Centers for Disease Control and Prevention show.The speed at which the JN.1 variant has sprea # Nursing # Pediatrics # Internal Medicine # Pharmacy 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
HealthDay 28 December at 04.55 PM Nirsevimab Protects Infants Against RSV-Linked Hospitalization Nirsevimab is efficacious for preventing hospitalization for respiratory syncytial virus (RSV)-associated lower respiratory tract infection among infants, according to a study published in the Dec. 28 issue of the New England Journal of Medicine.Simon B. Drysdale, Ph.D., from the Centre for Neonatal and Paediatric Infections at the Un # Pediatrics # Pharmacy # Family Practice # Infectious Disease 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
HealthDay 21 December at 11.21 PM Many U.S. Nursing Home Residents Have Not Been Vaccinated for Flu, COVID-19, or RSV for 2023-24 Many nursing home residents and adults have not been vaccinated for influenza, COVID-19, or respiratory syncytial virus (RSV) for the 2023 to 2024 season, according to research published in the Dec. 22 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Hannah E. Reses, M.P.H., from the C # Nursing # Internal Medicine # Pharmacy # Family Practice 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn

HealthDay 14 December at 05.00 PM Single Dose of mRNA-1345 Vaccine Safe, Effective Against RSV in Seniors A single dose of mRNA-1345 vaccine is safe and results in lower incidence of respiratory syncytial virus (RSV)-associated disease in older patients, according to a study published in the Dec. 14 issue of the New England Journal of Medicine.Eleanor Wilson, M.D., from Moderna in Cambridge, Massachusetts, and colleagues conducted a rando # Internal Medicine # Pharmacy # Infectious Disease # Geriatrics 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn


MedScape 28 November at 01.50 AM Sleep-Disordered Breathing Common After Stroke Sleep-disordered breathing remains common after stroke, affecting 60% of patients and showing no decline in prevalence from 2010 to 2023, a new meta-analysis suggested. 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medpage Today 24 November at 08.00 PM IDH Inhibitor Activity in Brain Cancer Persists With Longer Follow-Up HOUSTON -- Progression-free survival (PFS) in IDH-mutant low-grade glioma remained twice as high in adults who received vorasidenib (Voranigo) after surgery versus placebo, according to a follow-up analysis of a pivotal clinical... 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medical xPress 23 November at 01.50 PM RNA editing is the next frontier in gene therapy—here's what you need to know The United States Food and Drug Administration has just approved the first-ever clinical trial that uses CRISPR-Cas13 RNA editing. Its aim is to treat an eye disease called wet age-related macular degeneration that causes vision loss in millions of older people worldwide. 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
HealthDay 22 November at 04.44 PM Semaglutide, Liraglutide May Reduce Hospitalization Risk for Alcohol Use Disorder Semaglutide and liraglutide are associated with a reduced risk for hospitalization due to alcohol use disorder (AUD), according to a study published online Nov. 13 in JAMA Psychiatry.Markku Lähteenvuo, M.D., Ph.D., from the University of Eastern Finland in Kuopio, and colleagues conducted an observational study in Sweden using data from 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medpage Today 17 November at 10.31 PM Two Treatments That Don't Work for Osteoarthritis WASHINGTON -- If you're looking for nonsurgical osteoarthritis (OA) treatments with fewer side effects than ordinary pain relievers, two randomized trials presented here with negative results should at least narrow your search... 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
MedScape 11 November at 07.56 AM Scoring System Could Mean Better Access to Lung Transplant Scoring system could improve access for hard-to-match candidates due to height and blood type. 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn

Medical xPress 07 November at 07.50 AM How key results could influence health policy The results of some congressional races may foreshadow who will have outsize health policy influence in Congress next year. 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medpage Today 05 November at 07.00 PM Mpox Cases in Congo May Be Stabilizing GOMA, Congo -- Some health officials say mpox cases in Congo appear to be "stabilizing" -- a possible sign that the main epidemic for which the World Health Organization (WHO) made a global emergency declaration in August... 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medical xPress 02 November at 07.40 AM Insulin resistance caused by sympathetic nervous system over-activation, a paradigm-shifting study finds Rutgers Robert Wood Johnson Medical School and collaborating institutions have found that overnutrition leads to insulin resistance and metabolic disorders through increased activity of the sympathetic nervous system (SNS). The study shows that reducing SNS activity can prevent insulin resistance induced by a high-fat diet, suggesting a new understanding of how obesity causes insulin resistance. 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
MedScape 31 October at 06.30 AM Report: Rethink Race-Based Adjustments in Clinical Tools The slow adoption of race-neutral tools may harm patient care outcomes, according to a new report from the National Academies of Sciences, Engineering, and Medicine. 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn